Does USTEKINUMAB Cause Myocardial infarction? 362 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 362 reports of Myocardial infarction have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.4% of all adverse event reports for USTEKINUMAB.
362
Reports of Myocardial infarction with USTEKINUMAB
0.4%
of all USTEKINUMAB reports
53
Deaths
182
Hospitalizations
How Dangerous Is Myocardial infarction From USTEKINUMAB?
Of the 362 reports, 53 (14.6%) resulted in death, 182 (50.3%) required hospitalization, and 67 (18.5%) were considered life-threatening.
Is Myocardial infarction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 362 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Myocardial infarction?
ROSIGLITAZONE (17,018)
TESTOSTERONE (3,396)
ADALIMUMAB (3,214)
SACUBITRIL\VALSARTAN (3,120)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391)
APIXABAN (2,010)
TICAGRELOR (1,749)
LENALIDOMIDE (1,712)
ETANERCEPT (1,693)
METFORMIN\ROSIGLITAZONE (1,640)
Which USTEKINUMAB Alternatives Have Lower Myocardial infarction Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE